文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

继发性铁过载与肝脏:综述

Secondary Iron Overload and the Liver: A Comprehensive Review.

作者信息

Pinyopornpanish Kanokwan, Tantiworawit Adisak, Leerapun Apinya, Soontornpun Atiwat, Thongsawat Satawat

机构信息

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

出版信息

J Clin Transl Hepatol. 2023 Aug 28;11(4):932-941. doi: 10.14218/JCTH.2022.00420. Epub 2023 Feb 1.


DOI:10.14218/JCTH.2022.00420
PMID:37408825
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10318281/
Abstract

Iron overload is a condition involving excessive iron deposit in various organs, the liver being the main target organ for iron deposition and overload which are associated with significant liver morbidity and mortality. Iron overload can be categorized into primary and secondary causes. Primary iron overload, so-called hereditary hemochromatosis, is a well-recognized disease with available standard treatment recommendations. However, secondary iron overload is a more diverse disease with many unclear areas to be explored. Secondary iron overload is more prevalent than primary iron overload and occurs as a consequence of various causes which differ significantly across geographic regions. The main causes of secondary iron overload are iron-loading anemias, and chronic liver disease. The liver-related outcomes, patient outcomes, and treatment recommendations in these patients differ depending on the cause of iron overload. This review summarizes the causes, pathophysiology, liver-related outcomes, disease outcomes, and treatments of secondary iron overload.

摘要

铁过载是一种涉及铁在各个器官过度沉积的病症,肝脏是铁沉积和过载的主要靶器官,这与显著的肝脏发病率和死亡率相关。铁过载可分为原发性和继发性病因。原发性铁过载,即所谓的遗传性血色素沉着症,是一种已得到公认的疾病,有可用的标准治疗建议。然而,继发性铁过载是一种更为多样的疾病,有许多尚待探索的不明确领域。继发性铁过载比原发性铁过载更为普遍,它是由各种病因导致的,而这些病因在不同地理区域有显著差异。继发性铁过载的主要病因是铁负荷性贫血和慢性肝病。这些患者的肝脏相关结局、患者结局以及治疗建议因铁过载的病因不同而有所差异。本综述总结了继发性铁过载的病因、病理生理学、肝脏相关结局、疾病结局以及治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f603/10318281/c4cb07c44404/JCTH-11-932-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f603/10318281/4d00abc22540/JCTH-11-932-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f603/10318281/c4cb07c44404/JCTH-11-932-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f603/10318281/4d00abc22540/JCTH-11-932-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f603/10318281/c4cb07c44404/JCTH-11-932-g002.jpg

相似文献

[1]
Secondary Iron Overload and the Liver: A Comprehensive Review.

J Clin Transl Hepatol. 2023-8-28

[2]
Iron overload disorders: natural history, pathogenesis, diagnosis, and therapy.

Crit Rev Clin Lab Sci. 1983

[3]
Hemochromatosis: pathophysiology, evaluation, and management of hepatic iron overload with a focus on MRI.

Expert Rev Gastroenterol Hepatol. 2018-7-19

[4]
Liver cirrhosis as a consequence of iron overload caused by hereditary nonspherocytic hemolytic anemia.

World J Gastroenterol. 2005-2-28

[5]
Molecular pathogenesis and clinical consequences of iron overload in liver cirrhosis.

Hepatobiliary Pancreat Dis Int. 2016-10

[6]
The Evolution of Iron-Related Comorbidities and Hospitalization in Patients with Hemochromatosis: An Analysis of the Nationwide Inpatient Sample.

Blood Sci. 2023-1-17

[7]
Mice lacking liver-specific β-catenin develop steatohepatitis and fibrosis after iron overload.

J Hepatol. 2017-3-22

[8]
Hepatic iron overload in alcoholic end-stage liver disease is associated with iron deposition in other organs in the absence of HFE-1 hemochromatosis.

Liver Int. 2005-6

[9]
Prevalence of hepatic iron overload and association with hepatocellular cancer in end-stage liver disease: results from the National Hemochromatosis Transplant Registry.

Liver Int. 2007-12

[10]
Secondary iron overload disorders.

Semin Hematol. 1998-1

引用本文的文献

[1]
Extracellular Vesicles as Biomarkers in Chronic Hepatobiliary Diseases: An Overview of Their Interplay.

Int J Mol Sci. 2025-6-30

[2]
Proteomics-Based Exploration of the Hepatoprotective Mechanism of α-Lipoic Acid in Rats with Iron Overload-Induced Liver Injury.

Int J Mol Sci. 2025-5-16

[3]
Magnetic sculpture-like tumor cell vaccines enable targeted immune activation and potent antitumor effects.

Theranostics. 2025-4-13

[4]
Hepatic Iron Overload and Hepatocellular Carcinoma: New Insights into Pathophysiological Mechanisms and Therapeutic Approaches.

Cancers (Basel). 2025-1-24

[5]
Non-HFE Hemochromatosis in the Context of β-Thalassemia Trait: A Case Study on Iron Overload Dysregulation.

Cureus. 2024-11-25

[6]
Impact of body fat composition on liver iron overload severity in hemochromatosis: a retrospective MRI analysis.

Radiol Med. 2025-2

[7]
Unbiased and reproducible liver MRI-PDFF estimation using a scan protocol-informed deep learning method.

Eur Radiol. 2025-5

[8]
Mild Systemic Inflammation Increases Erythrocyte Fragility.

Int J Mol Sci. 2024-6-27

[9]
Hemochromatosis-How Not to Overlook and Properly Manage "Iron People"-A Review.

J Clin Med. 2024-6-23

[10]
The Effects and Safety of Silymarin on β-thalassemia in Children and Adolescents: A Systematic Review based on Clinical Trial Studies.

Rev Recent Clin Trials. 2024

本文引用的文献

[1]
Association of Plasma Iron Status with Subsequent Risk of Total and Site-Specific Cancer: A Large Case-Cohort Study within JPHC Study.

Cancer Prev Res (Phila). 2022-10-4

[2]
Severe Cardiovascular Complications Following Liver Transplantation in Patients With Iron Overload.

JACC Case Rep. 2022-6-1

[3]
Post-mortem liver and bone marrow iron quantification in haemodialysis patients: A prospective cohort study.

EBioMedicine. 2022-3

[4]
Hepatitis B-Associated Symptomatic Iron Overload, with Complete Resolution after Nucleoside Analogue Treatment.

Case Rep Gastrointest Med. 2021-12-27

[5]
Serum Biomarkers of Iron Status and Risk of Hepatocellular Carcinoma Development in Patients with Nonalcoholic Fatty Liver Disease.

Cancer Epidemiol Biomarkers Prev. 2022-1

[6]
Hyperferritinemia-A Clinical Overview.

J Clin Med. 2021-5-7

[7]
Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with NAFLD.

J Hepatol. 2021-9

[8]
Liver complications of haemoglobin H disease in adults.

Br J Haematol. 2021-1

[9]
Clinical Factors Associated with Hepatocellular Iron Deposition in End-stage Liver Disease.

J Clin Transl Hepatol. 2020-9-28

[10]
Analysis of determinant factors of liver fibrosis progression in ex-thalassemic patients.

Int J Hematol. 2021-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索